Metabolic dysfunction-associated steatohepatitis (MASH)

Our proprietary network, NASH Clinical, is a global network of clinicians and investigators that includes endocrinologists, gastroenterologists, diabetologists, and general internists with connections to hospitals worldwide. They have vast experience as a group and are devoted to improving MASH (NASH) trials.

The leading experts of the NASH Think Tank meet on a regular basis to discuss the current state of the field and innovative approaches for MASH (formerly known as NASH) studies. Under Dr. Castro Cabezas’ leadership, they work to increase understanding of MASH, create expert centres for MASH clinical trials, and help provide better patient recruitment and retention rates for MASH Sponsors.

To help in the early identification of MASH patients, Julius Clinical initiated the Global Research Initiative for Patients screening on NASH (GRIP on NASH) research project. This is a multinational program in which at-risk patients are screened for MASLD and MASH (formerly known as NAFLD and NASH). Through GRIP on NASH, the number of patients per site per year could be doubled or even tripled, greatly alleviating the difficulty of a depleted MASH patient population.

We are dedicated to providing fast, high-quality patient recruitment and retention rates for MASH clinical trials, Our team has years of experience and will provide a tailor-made solution that suits your trial’s exact needs.